학술논문

Phase II study of lapatinib in combination with vinorelbine, as first- or second-line therapy in women with HER2-overexpressing metastatic breast cancer
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2013, 31 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755